Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer

Clinical Cancer Research

Volumn 5, Issue 12, 1999, Pages 4175-4181

  Li, Daqing ^a   Duan, Ling ^a   Freimuth, Paul ^b   O'Malley Jr , Bert W ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RECEPTOR;

ARTICLE; DOSE RESPONSE; DRUG EFFICACY; GENE THERAPY; GENE TRANSFER; GENETIC VARIABILITY; HEAD AND NECK CANCER; HUMAN; HUMAN ADENOVIRUS 2; HUMAN CELL; MARKER GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TUMOR SUPPRESSOR GENE;

ADENOVIRUSES, HUMAN; ANIMALS; CARCINOMA, SQUAMOUS CELL; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HEAD AND NECK NEOPLASMS; HUMANS; INTERLEUKIN-2; LUMINESCENT PROTEINS; MICE; RECEPTORS, VIRUS; THYMIDINE KINASE; TUMOR CELLS, CULTURED;

EID: 0033373328     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Landis, S. H., Murray, T., Bolden, S., and Wingo, P. A. Cancer statistics. CA Cancer J. Clin., 1: 6-29, 1998.
2. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer statistics. CA Cancer J. Clin., 1: 5-27, 1997.
3. Wingo, P. A., Tong, T., and Bolden, S. Cancer statistics. CA Cancer J. Clin., 45: 8-30, 1995.
4. American Cancer Society Facts and Figures. Publ. No. 93-400. Washington, DC: American Cancer Society, 1993.
5. O'Malley, B. W., Jr., Chen, S. H., Schwartz, M. R., and Woo, S. L. C. Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model. Cancer Res., 55: 1080-1085, 1995.
6. Clayman, G. L., Liu, T. J., Overholt, S. M., Mobley, S. R., Wang, M., Janot, F., and Goepfert, H. Gene therapy for head and neck cancer. Arch. Otolaryngol., 122: 489-493, 1996.
7. Goebel, E. A., Davison, B. L., Graham, S. M., Zabner, J., and Kern, J. A. Adenovirus-mediated gene therapy for head and neck squamous cell carcinomas. Ann. Otol. Rhinol. Laryngol., 105: 562-567, 1996.
8. Clayman, G. L., El-Naggar, A. K., Roth, J. A., Zhang, W. W., Goepfert, H., Taylor, D. L., and Liu, T. J. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res., 55: 1-6, 1995.
9. Breau, R. L., and Clayman, G. L. Gene therapy for head and neck cancer. Curr. Opin. Oncol., 8: 227-231, 1996.
10. O'Malley, B. W., Jr., Cope, K. A., Chen, S. H., Li, D., Schwartz, M. R., and Woo, S. L. C. Combination gene therapy for oral cancer in a murine model. Cancer Res., 56: 1737-1741, 1996.
11. Sewell, D. A., Li, D., Duan, L., Schwartz, M. R., and O'Malley, B. W., Jr. Optimizing suicide gene therapy for head and neck cancer. Laryngoscope, 107: 1490-1495, 1997.
12. Wilson, K. M., Stambrook, P. J., Bi, W. L., Pavelic, Z. P., Pavelic, L., and Gluckman, J. L. HSV-tk gene therapy in head and neck squamous cell carcinoma. Arch. Otolaryngol., 122: 746-749, 1996.
13. INK4A adenovirus-mediated gene therapy for human head and neck squamous cell cancer. Clin. Cancer Res., 4: 1697-1704, 1998.
14. Londberg-Holm, K., and Philipson, L. Early events of virus-cell interactions in an adenovirus system. J. Virol., 4: 323-338, 1969.
15. Bergelson, J. M., Cunningham, J. A., Droguett, G., Kurt-Jones, E. A., Krithivas, A., Hong, J. S., Horwitz, M. S., Crowell, R. L., and Finberg, R. W. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science (Washington DC), 275: 1320-1323, 1997.
16. Devaux, C., Caillet-Boudin, M. L., Jacrot, B., and Boulanger, P. Crystallization, enzymatic cleavage, and the polarity of the adenovirus type 2 fiber. Virology, 161: 121-128, 1987.
17. Bai, M., Campisi, L., and Freimuth, P. Vitronectin receptor antibodies inhibit infection of HeLa and A549 cells by adenovirus type 12 but not by adenovirus type 2. J. Virol., 68: 5925-5932, 1994.
18. Freimuth, P. Human cell line selected for resistance to adenovirus infection has reduced levels of the virus receptor. J. Virol., 70: 4081-4085, 1996.
19. Liggett, W. H., Jr., Sewell, D. A., Rocco, J., Arhent, S., and Sidransky, D. p16 and p16β are potent growth suppressors of head and neck squamous carcinoma cells in vitro. Cancer Res., 56: 4119-4123, 1996.
20. Chen, S. H., Shine, H. D., Goodman, J. C., Grossman, R. G., and Woo, S. L. Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc. Natl. Acad. Sci. USA, 91: 3054-3057, 1994.
21. Graham, F., and Prevec, L. Methods in Molecular Biology: Gene Transfer and Expression Protocols. Totowa, NJ: Humana Press, 1991.
22. He, T. C., Zhou, S., Da Costa, L. T., Yu, J., Kinzler, K. W., and Vogelstein, B. A. Simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA, 95: 2509-2514, 1998.
23. Mosman, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65: 55-63, 1983.
24. Hsu, K. H., Lonberg-Holm, K., Alstein, B., and Crowell, R. L. A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses. J. Virol., 62: 1647-1652, 1988.
25. Roth, J. A., and Cristiano, R. J. Gene therapy for cancer: what have we done and where are we going? J. Natl. Cancer Inst., 89: 21-39, 1997.
26. O'Malley, B. W., Jr., Duane, A. S., Li, D., Kosai, K., Chen, S. H., Woo, S. L. C., and Duan, L. The role of interleukin-2 in combination adenovirus gene therapy for head and neck cancer. Mol. Endocrinol., 111: 667-673, 1997.
27. O'Malley, B. W., Jr., Li, D., Buckner, A., Duan, L., Woo, S. L. C., and Pardoll, D. M. Limitations of adenovirus-mediated interleukin-2 gene therapy for oral cancer. Laryngoscope, 109: 389-395, 1999.
28. Hidaka, C., Milano, E., Leopold, P. L., Bergelson, J. M., Hackett, N. R., Finberg, R. W., Wickham, T. J., Kovesdi, I., Roelvink, R, and Crystal, R. G. CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts. J. Clin. Investig., 103: 579-587, 1999.